Diabetic Neuropathy in Spinal Cord Stimulator Patients
Spinal Cord Stimulation Improves Pain, Arterial Stiffness and Vascular Flow in Lower Extremities in Patients With Diabetes Mellitus Type II A Multidisciplinary Collaborative Prospective Study
University of Chicago
25 participants
Jan 27, 2022
OBSERVATIONAL
Conditions
Summary
The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.
Eligibility
Inclusion Criteria5
- Patients with DM type 2 of more than 1-year duration
- DM stage 3 or less
- Patients ≥18 years of age
- Refractory painful diabetic peripheral neuropathy of the lower extremities
- ABI index \<0.9
Exclusion Criteria10
- Patients on anticoagulants
- Patients with active infections
- Patients with HbA1\>10
- Psychiatric disorders and cognitive dysfunctions
- Illicit Drug Usage
- Patients on dialysis
- BMI\>35.0
- Surgery within the last 30 days
- Ulcer of the lower extremities
- Calcification of the peripheral arteries
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04687215